Aclarion (ACON) said Monday Scripps Health will add its Nociscan technology platform to help find sources of chronic low back pain at Scripps facilities in San Diego area.
Shares surged 123% as intraday trading volume soared to more than 69 million shares from a daily average of about 646,000.
BioXcel Therapeutics (BTAI) said Monday that the US Food and Drug Administration has concluded that the inspection of a single site in its TRANQUILITY II Phase 3 trial is closed.
The company said the conclusion further supports reliability of data from the trial of BXCL501.
Shares more than doubled as trading volume catapulted to over 138 million from a daily average of about 1.91 million.
Allegro MicroSystems (ALGM) shares soared 17% after Bloomberg reported Sunday ON Semiconductor (ON) is working on a potential acquisition of Allegro.
Over 7.3 million shares traded intraday versus a daily average of roughly 2.45 million.
Price: 8.44, Change: +5.09, Percent Change: +151.88
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。